Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 6076-6082
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6076
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6076
Figure 1 Clinical application of the new defining system in resected pancreatic head cancer.
For example, a patient who has a 2 cm-sized tumor with preoperative CA19-9 120 U/mL and initial total bilirubin 1.2 mg/dL can be described according to the proposed new defining system as follows: (A) R2cm-H-120 (1.2); (B) BR2cm-Hn-SMV (0.5cm/30%)-120 (1.2); (C) BR2cm-Hu-SMA (0.5 cm/20%)-120(1.2); (D) BR2cm-Hn-SMV (0.5cm/50%)-120 (1.2)-Arha; (E) R2cm-H-pylorus-120 (1.2); (F) R2cm-H-T colon mesentery-120 (1.2).
- Citation: Yang SJ, Hwang HK, Kang CM, Lee WJ. Preoperative defining system for pancreatic head cancer considering surgical resection. World J Gastroenterol 2016; 22(26): 6076-6082
- URL: https://www.wjgnet.com/1007-9327/full/v22/i26/6076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i26.6076